MATINAS BIOPHARMA HOLDINGS, INC. Operating Lease, Liability, Noncurrent
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Operating Lease, Liability, Noncurrent of $464.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-03-31: Operating Lease, Liability, Noncurrent $464.00K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $653.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $1.47M.
- 2025-06-30: Operating Lease, Liability, Noncurrent $1.70M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-03-31 | $464.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $653.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.47M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.91M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.12M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.32M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.51M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.70M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.88M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $3.05M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $3.22M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.38M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $3.53M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $3.68M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $3.84M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.99M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.14M 10-K · filed 2023-03-15 | $4.14M 10-K · filed 2022-03-08 |
| 2021-09-30 | $4.28M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $3.12M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $3.21M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.30M 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $3.39M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $3.47M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.58M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.70M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $3.81M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $3.92M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $4.02M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |